CoChat

Telomerase-deficient mice with short telomeres are resistant to skin tumorigenesis

González-Suárez, Eva, Samper, Enrique, Flores, Juana M., Blasco, María A. · 2000 · Nature Genetics

The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.

Abstract

Inhibition of telomerase is proposed to limit the growth of cancer cells by triggering telomere shortening and cell death. Telomere maintenance by telomerase is sufficient, in some cell types, to allow immortal growth. Telomerase has been shown to cooperate with oncogenes in transforming cultured primary human cells into neoplastic cells, suggesting that telomerase activation contributes to malignant transformation. Moreover, telomerase inhibition in human tumour cell lines using dominant-negative versions of TERT leads to telomere shortening and cell death. These findings have led to the proposition that telomerase inhibition may result in cessation of tumour growth. The absence of telomerase from most normal cells supports the potential efficacy of anti-telomerase drugs for tumour therapy, as its inhibition is unlikely to have toxic effects. Mice deficient for Terc RNA (encoding telomerase) lack telomerase activity, and constitute a model for evaluating the role of telomerase and telomeres in tumourigenesis. Late-generation Terc-/- mice show defects in proliferative tissues and a moderate increase in the incidence of spontaneous tumours in highly proliferative cell types (lymphomas, teratocarcinomas). The appearance of these tumours is thought to be a consequence of chromosomal instability in these mice. These observations have challenged the expected effectiveness of anti-telomerase-based cancer therapies. Different cell types may nonetheless vary in their sensitivity to t…

Overview

Integrity signals

Registry

Crossref · 10.1038/79089

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Research works printed but not linked: 1

  1. Hennings, H. Primary culture of keratinocytes from newborn mouse epidermis in medium with lowered levels of Ca2+. in Keratinocyte Methods (eds Leigh, I.M. & Watt, F.M.) 21–23 (Cambridge University Press, New York, 1994).

Cited by

See all 348

Metadata

Authors
González-Suárez, E., Samper, E., Flores, J. M., & Blasco, M. A.
Affiliations
  • Centro Nacional de Biotecnología (ES)
  • Universidad Complutense de Madrid (ES)
Venue
Nature Genetics
Published
2000-09
Volume
26
Issue
1
Pages
114-117
ISSN
  • 1061-4036 (ISSN-L)
  • 1546-1718
OpenAlex
W1573467049
Cited by
347
References
29
Citations by year
2026: 3 · 2025: 3 · 2024: 4 · 2023: 6 · 2022: 4 · 2021: 8 · 2020: 11 · 2019: 9 · 2018: 2 · 2017: 5 · 2016: 11 · 2015: 7 · 2014: 7 · 2013: 21 · 2012: 14
FWCI
17.35
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Nature Genetics (publishedVersion)
  • PubMed (publishedVersion)
Funders
European Commission
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
  • Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Keywords
telomerase, telomere shortening, skin carcinogenesis, chromosomal instability, lymphoma, teratocarcinoma, epithelial tumors, telomere maintenance, malignant transformation
MeSH terms
Animals, Carcinogens, Flow Cytometry, Immunity, Innate, Immunohistochemistry, Mice, Inbred C57BL, Mice, Mutant Strains, Papilloma, Skin, Skin Neoplasms, Tetradecanoylphorbol Acetate, Time Factors, 9,10-Dimethyl-1,2-benzanthracene, Keratinocytes, Tumor Suppressor Protein p53, Proto-Oncogene Proteins p21(ras), Telomere, In Situ Hybridization, Fluorescence, Telomerase, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.